Gaudium IVF: Promoter Group Confirms No Share Encumbrance for FY26
Gaudium IVF and Women Health Limited disclosed that its promoter group has not encumbered any shares as of March 31, 2026. This annual filing under SEBI Takeover Regulations confirms no indirect or direct encumbrance on the company's shares by promoters or persons acting in concert.
This is a standard annual disclosure requirement under SEBI regulations. The confirmation of no encumbrance is expected and does not represent a significant new development that would materially impact the company's stock or operations.
The announcement is a routine regulatory filing confirming no encumbrance on shares, which is a neutral event. It does not indicate any positive or negative development for the company.
Gaudium IVF and Women Health Limited has submitted its annual disclosure under Regulation 31(4) of the SEBI (Substantial Acquisition of Shares and Takeovers) Regulations, 2011. The disclosure, received from the Promoter and Promoter Group including Persons Acting in Concert, confirms that there has been no encumbrance on the shares of the company, directly or indirectly, as of the financial year ended March 31, 2026.
The declaration was made by Dr. Manika Khanna, one of the promoters, on behalf of the entire promoter group. The announcement also lists the members of the Promoter and Promoter Group, including individuals such as Dr. Peeyush Khanna, Mr. Vishad Khanna, Dr. Gautam Anand, and entities like EKK Hospitality Private Limited and Gaudium Foundation.
The company has submitted this disclosure to BSE Limited and the National Stock Exchange of India Limited for their records.
What to do with a filing like this
Gaudium IVF and Women Health Limited filed this with the NSE as a statutory disclosure, categorised under substantial acquisition of shares and takeovers. It is a primary document, not a recommendation, and the desk marks it low impact, the band that almost never moves a portfolio on its own.
That call is the part a filing cannot make for you. On RealCase, SEBI-registered research analysts and investment advisers read announcements like this one and turn the ones that matter into actions inside their model portfolios: a change in weight, a hold, or nothing at all. You are not left working out which of the roughly 250 filings published each day needs a response. The portfolio you follow is updated when a filing actually warrants it, with the reason written down.
See the model portfoliosA plain-language summary of a public exchange filing by Gaudium IVF and Women Health Limited. Read the original for the full detail.